38th Annual New Treatments in Chronic Liver Disease CME Conference
March 18, 2024
Coronado Island Marriott Resort and Spa, 2000 2nd Street, Coronado, California, 92118, United States
Mark your calendar for the upcoming conference on March 16 and 17, 2024, delving into the latest medications and therapies in liver treatment and transplantation. Explore trial results and real-world data on oral drugs for chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. "New Treatments in Chronic Liver Disease" offers a comprehensive yet concise program, ensuring physicians stay updated on common challenges in liver disease treatment.
Engage in advancing personalized therapies for rare and common kidney diseases at the 6th CKD Drug Development Summit from March 19 to 21, 2024. Explore groundbreaking clinical strides like SGLT2s, GLP-1s, and ERAs for CKD. Delve into enhanced surrogate markers for outcomes, new targets, and pioneering research. This summit unites 200+ biopharma stakeholders across scientific, clinical, and outcomes realms for three days of focused discourse. The premier platform for industry leaders, regulators, and experts to propel kidney innovation toward the future of drug development.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our